Login
$DYNC
$10.91 +$0.04 (0.32%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Current assets
Cash and cash equivalents
Due from Sponsor
Related Party
Total due from Sponsor
Prepaid expenses
Total current assets
Long-term prepaid insurance
Investments held in Trust Account
Total Assets
Liabilities and Equity
Current liabilities
Accounts payable
Accounts payable and accrued expenses
Accrued offering costs
Over-allotment option liability
Due to related party
Total current liabilities
Warrant liability
Deferred underwriting fee
Total Liabilities
Class A ordinary shares subject to possible redemption, 16,600,000 shares at redemption value of $10.36 and $10.07 per share as of September 30, 2025 and December 31, 2024, respectively
Class A Ordinary Shares
Total class A ordinary shares subject to possible redemption, 16,600,000 shares at redemption value of $10.36 and $10.07 per share as of September 30, 2025 and December 31, 2024, respectively
Class A ordinary shares subject to possible redemption, 16,600,000 shares at redemption value of $10.61 and $10.45 per share as of June 30, 2026 and December 31, 2025, respectively
Shareholders’ Equity (Deficit)
Ordinary shares, value
Retained earnings (Accumulated deficit)
Total Shareholders’ Equity (Deficit)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Equity (Deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support